| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | Mar 04, 2024 | Sale | $11.12 | 3,760 | 41,816 | 190,424 | Mar 06, 2024, 05:14 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | Nov 21, 2023 | Sale | $1.98 | 1,850 | 3,661 | 46,634 | Nov 21, 2023, 05:47 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | May 31, 2023 | Sale | $7.17 | 3,293 | 23,612 | 43,609 | Jun 02, 2023, 08:31 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | Mar 02, 2023 | Sale | $15.83 | 1,434 | 22,696 | 18,119 | Mar 06, 2023, 06:52 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | Nov 21, 2022 | Sale | $18.19 | 1,720 | 31,289 | 19,535 | Nov 22, 2022, 07:06 PM | |
| ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | SVP and General Counsel | Jun 02, 2022 | Sale | $19.73 | 1,795 | 35,419 | 16,380 | Jun 02, 2022, 04:48 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Matsuda Masaru | SVP, General Counsel | Sep 04, 2021 | Option Exercise | $42.22 | 3,412 | 144,055 | 20,049 | Sep 07, 2021, 05:42 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Matsuda Masaru | SVP, General Counsel | Feb 10, 2021 | Option Exercise | $50.60 | 3,203 | 162,072 | 14,496 | Feb 12, 2021, 07:10 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Matsuda Masaru | SVP, General Counsel | Feb 12, 2021 | Option Exercise | $49.84 | 2,047 | 102,022 | 16,578 | Feb 12, 2021, 07:10 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Matsuda Masaru | SVP, General Counsel | Sep 04, 2020 | Option Exercise | $27.70 | 2,380 | 65,926 | 11,442 | Sep 04, 2020, 06:13 PM | |
| HALO | HALOZYME THERAPEUTICS, INC. | Matsuda Masaru | SVP, General Counsel | Feb 12, 2020 | Option Exercise | $20.00 | 1,681 | 33,620 | 6,938 | Feb 13, 2020, 06:41 PM |
Menu